Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegaptanib to Prevent CME Worsening Post-Cataract Surgery
NCT00346983Phase 2Terminated
- Sponsor
- Johns Hopkins University
- Start
- Jun 2006
- Primary completion
- Apr 2007
- Modality
- Antisense DNA, RNA Aptamers, Small Interfering RNA (siRNA)
- Countries
- 1
01
Overview
A Phase 2 trial of pegaptanib sodium in cystoid macular edema (CME), sponsored by Johns Hopkins University. Started Jun 2006; status: terminated.
02
Drugs
pegaptanib sodium
03
Conditions
cystoid macular edema (CME)
Beyond the preview
Go deeper on NCT00346983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00346983.